Table 1. Patients’ characteristics and their correlation with serum survivin.

Characteristics	Percentage (%)	R& (correlated with serum survivin)
Stage	I, 23.5%; II, 58.8%; III, 5.9%; IV, 11.8%	0.302
Sex	Female, 41.2%; male, 58.8%	0.074
Age	Mean, 44.9 years (range, 15 to 74 years)	−0.394
IPI scores	0, 29.4%; 1, 35.3%; 2, 29.4%; 3, 5.9%	0.413
LDH	Increased, 35.3%; normal, 64.7%	0.627** (P=0.007)
B symptom	Absent, 47.1%; present, 52.9%	0.127
ECOG scores	0, 41.2%; 1, 470.1%; 2, 11.8%	0.346
OS	Mean, 3 years (range, 0.4 to 7.2 years)	−0.644** (P=0.005)
Survivin	Positive, 17.6%; negative, 82.4%	1.0

**, correlation is significant at the 0.01 level (2-tailed); ^&, correlation coefficient. IPI, international prognosis index; LDH, Lactic dehydrogenase; ECOG, Eastern Cooperative Group performance score; OS, overall survival time.